CSPC Pharmaceutical Group
CSPC Pharmaceutical Group is a pharmaceutical group in China.
Launch date
Market cap
$6.4b
Enterprise valuation
$4.8b (Public information from Sep 2024)
Share price
HKD5.04 1093.HK
Shijiazhuang Hebei (HQ)
Financials
Estimates*
| CNY | 2019 | 2020 | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|---|---|
| Revenues | 22.1b | 24.9b | 27.9b | 30.9b | 31.5b | 302.3b |
| % growth | - | 13 % | 12 % | 11 % | 2 % | - |
| EBITDA | 5.4b | 6.9b | 7.7b | 8.6b | 8.5b | - |
| % EBITDA margin | 24 % | 28 % | 28 % | 28 % | 27 % | - |
| Profit | 3.7b | 5.2b | 5.6b | 6.1b | 5.9b | - |
| % profit margin | 17 % | 21 % | 20 % | 20 % | 19 % | - |
| R&D budget | 2.0b | 2.9b | 3.4b | 4.0b | 4.8b | - |
| R&D % of revenue | 9 % | 12 % | 12 % | 13 % | 15 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | Early VC | |
| Total Funding | - | ||
Related Content
Recent News about CSPC Pharmaceutical Group
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
